FDA Adverse Event Injury Summary report: N

INFUSE BONE GRAFT

MDR report key: 3180670 · Received June 20, 2013

Report

Report Number
1030489-2013-02440
Event Type
Injury
Date Received
June 20, 2013
Report Date
August 15, 2016
Manufacturer
MEDTRONIC SOFAMOR DANEK USA, INC
Product Code
NEK
PMA / PMN Number
P000058
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MN, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

(B)(4): NEITHER THE DEVICE NOR FILMS OF APPLICABLE IMAGING STUDIES WERE RETURNED TO THE MANUFACTURER FOR EVALUATION. THEREFORE, WE ARE UNABLE TO DETERMINE THE DEFINITIVE CAUSE OF THE REPORTED EVENT.

Additional Manufacturer Narrative · 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

IT WAS REPORTED BY A NON-MEDICAL PROFESSIONAL THAT THE PATIENT UNDERWENT A PROCEDURE FOR L3-L5 TLIF WHERE RHBMP-2 WAS IMPLANTED WITH INTERBODY SPACERS, AUTOGRAFT, ALLOGRAFT, AND DBM PUTTY. SUBSEQUENTLY, THE PATIENT WAS ALLEGEDLY DIAGNOSED WITH ECTOPIC BONE GROWTH, AN INFLAMMATORY REACTION TO RHBMP-2/ACS, CHRONIC PAIN, AND ADDITIONAL SURGERIES.

Description of Event or Problem · 1

IT WAS REPORTED THAT ON: (B)(6) 2007: THE PATIENT UNDERWENT THE FOLLOWING PROCEDURES: IRRIGATION AND DEBRIDEMENT OF LEFT FLANK STIMULATOR SITE. REMOVAL OF SPINAL CORD STIMULATOR LEADS AND BATTERY. L3-4 MAJOR DISCECTOMY WITH LAMINOFORAMINOTOMY. 4. L4-5 MAJOR DISCECTOMY WITH REVISION LAMINECTOMY. L3-4 AND L4-5 POSTERIOR INTERIOR-BODY ARTHRODESIS. L3-4 AND L4-5 INSERTION OF INTER-VERTEBRAL DEVICE. L3-4 AND L4-5 POSTEROLATERAL FUSION. L5-S1 REVISION POSTEROLATERAL FUSION. L3-4 NON-SEGMENTAL PEDICLE SCREW INSTRUMENTATION. L5 RE-INSERTION OF SPINAL FUSION. L5-S1 EXPLORATION OF SPINAL FUSION. MAJOR LEFT ILIAC CREST STRUCTURAL AUTOGRAFT HARVEST. MORCELLIZED ILIAC CREST BONE GRAFT. AS PER-OP NOTES, "AT L3-4, CANCELLOUS AUTOGRAFT WAS PACKED IN THE ANTERIOR DISK SPACE FOLLOWED BY A HALF STRIP OF BMP FOLLOWED BY PLACEMENT OF INTER-VERTEBRAL GRAFT AFTER ADEQUATELY HYDRATING IT FOR APPROPRIATE TIME. THIS WAS PERFORMED IN THE EXACT MANNER AT L4-5. THE CANCELLOUS AUTOGRAFT WAS SUBSEQUENTLY PLACED WITHIN THE INTERVAL IN THE LATERAL GUTTER BETWEEN THE L3 TRANSVERSE PROCESS AND THE LATERAL FUSION MASS AT L5-S1. THIS WAS FOLLOWED BY PLACEMENT OF CORTICAL CANCELLOUS STRIP, BMP AND DPM PUTTY AND CANCELLOUS MIXTURE."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
280583 INFUSE BONE GRAFT FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET NEK MEDTRONIC SOFAMOR DANEK USA, INC NA UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 39 YR Required Intervention